Risk factors for ANA positivity in healthy persons

Wandstrat A, Carr-Johnson F, Branch V, Gray H, Fairhurst A, Reimold A, Karp D, Wakeland E, Olsen N: Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun. 2006, 27: 153-160. 10.1016/j.jaut.2006.09.001.

Davidson A, Diamond B: Autoimmune diseases. N Engl J Med. 2001, 345: 340-350. 10.1056/NEJM200108023450506.

Chakravarty E, Bush T, Manzi S, Clarke A, Ward M: Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007, 56: 2092-2094. 10.1002/art.22641.

Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J, Harley J: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003, 349: 1526-1533. 10.1056/NEJMoa021933.

Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N, Schaller J, Talal N, Winchester R: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002/art.1780251101.

Li Q, Zhou J, Wandstrat A, Carr-Johnson F, Branch V, Karp D, Mohan C, Wakeland E, Olsen N: Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol. 2007, 147: 60-70.

Open Source Clustering Software. [ http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/ ]

Müller R, Heber B, Hashimoto T, Messer G, Müllegger R, Niedermeier A, Hertl M: Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol. 2009, 34: 898-903.

Blank M, Gisondi P, Mimouni D, Peserico A, Piaserico S, Shoenfeld Y, Reunala T, Zambruno G, Di Zenzo G, Girolomoni G: New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin Exp Rheumatol. 2006, 24: S20-25.

Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S: Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci. 2008, 52: 47-54. 10.1016/j.jdermsci.2008.04.013.

Polgár A, Falus A, Koó E, Ujfalussy I, Seszták M, Szuts I, Konrád K, Hodinka L, Bene E, Mészáros G, Ortutay Z, Farkas E, Paksy A, Buzás EI: Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford). 2003, 42: 522-527.

Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Muñoz S, Testi A, Plaza J, Sentís J, Coca A: Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus. 2008, 17: 281-288.

Meroni P, Schur P: ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010, 69: 1420-1422. 10.1136/ard.2009.127100.

Sheridan S, Pignone M, Mulrow C: Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003, 18: 1039-1052. 10.1111/j.1525-1497.2003.30107.x.

Fernandez S, Lobo A, Oliveira Z, Fukumori L, Périgo A, Rivitti E: Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med Sao Paulo. 2003, 58: 315-319.

Semchuk K, Rosenberg A, McDuffie H, Cessna A, Pahwa P, Irvine D: Antinuclear antibodies and bromoxynil exposure in a rural sample. J Toxicol Environ Health A. 2007, 70: 638-657. 10.1080/15287390600974593.

Heinlen L, Ritterhouse L, McClain M, Keith M, Neas B, Harley J, James J: Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med. 2010, 88: 719-727. 10.1007/s00109-010-0618-1.

Silverman G, Srikrishnan R, Germar K, Goodyear C, Andrews K, Ginzler E, Tsao B: Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol. 2008, 153: 102-116. 10.1111/j.1365-2249.2008.03680.x.

McGrogan A, Seaman H, Wright J, de Vries C: The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf). 2008, 69: 687-696. 10.1111/j.1365-2265.2008.03338.x.

Walsh J, Bremner A, Feddema P, Leedman P, Brown S, O'Leary P: Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010, 95: 1095-1104. 10.1210/jc.2009-1977.

Vynios DH, Tsagaraki I, Grigoreas GH, Samiotaki M, Panayotou G, Kyriakopoulou D, Georgiou P, Korbakis D, Panayotou A, Nanouri K, Assouti M, Andonopoulos AP: Autoantibodies against aggrecan in systemic rheumatic diseases. Biochimie. 2006, 88: 767-773. 10.1016/j.biochi.2006.01.004.

Tzaneva S, Volc-Platzer B, Kittler H, Hönigsmann H, Tanew A: Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study. Br J Dermatol. 2008, 158: 1050-1054. 10.1111/j.1365-2133.2008.08500.x.

Schmidt E, Tony H, Bröcker E, Kneitz C: Sun-induced life-threatening lupus nephritis. Ann N Y Acad Sci. 2007, 1108: 35-40. 10.1196/annals.1422.004.

Paradela S, Lorenzo J, Martínez-Gómez W, Yebra-Pimentel T, Valbuena L, Fonseca E: Interface dermatitis in skin lesions of Kikuchi-Fujimoto's disease: a histopathological marker of evolution into systemic lupus erythematosus?. Lupus. 2008, 17: 1127-1135. 10.1177/0961203308092161.

Wenzel J, Tüting T: An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol. 2008, 128: 2392-2402. 10.1038/jid.2008.96.

Olsen N, Prather H, Li Q, Burns D: Autoantibody profiles in two patients with non-autoimmune muscle disease implicate a role for gliadin autoreactivity. Neuromuscul Disord. 2010, 20: 188-191. 10.1016/j.nmd.2009.12.008.

Bennett L, Palucka A, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003, 197: 711-723. 10.1084/jem.20021553.

Li Q, Zhou J, Lian Y, Zhang B, Branch V, Carr-Johnson F, Karp D, Mohan C, Wakeland E, Olsen N: Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol. 2010, 159: 281-291. 10.1111/j.1365-2249.2009.04057.x.

Ishii T, Onda H, Tanigawa A, Ohshima S, Fujiwara H, Mima T, Katada Y, Deguchi H, Suemura M, Miyake T, Miyatake K, Kawase I, Zhao H, Tomiyama Y, Saeki Y, Nojima H: Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 2005, 12: 429-439. 10.1093/dnares/dsi020.

Silveira IG, Burlingame RW, von Mühlen CA, Bender AL, Staub HL: Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol. 2007, 26: 1883-1889. 10.1007/s10067-007-0601-6.

GEO Accession viewer. [ http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24706 ]